Literature DB >> 24726890

Adropin: a new regulatory peptide in cardiovascular endocrinology.

Jens P Goetze1, Jakob Albrethsen2.   

Abstract

Entities:  

Keywords:  Adropin; Diabetes; Myocardial infarction; Natriuretic peptide; Obesity; Troponin

Mesh：

Substances：

Year:  2014        PMID： 24726890     DOI： 10.1016/j.regpep.2014.04.002

Source DB:  PubMed          Journal:  Regul Pept        ISSN： 0167-0115


× No keyword cloud information.
  9 in total

1.  Adropin and Inflammation Biomarker Levels in Male Patients With Obstructive Sleep Apnea: A Link With Glucose Metabolism and Sleep Parameters.

Authors:  Josko Bozic; Josip A Borovac; Tea Galic; Tina Ticinovic Kurir; Daniela Supe-Domic; Zoran Dogas
Journal:  J Clin Sleep Med       Date:  2018-07-15       Impact factor: 4.062

2.  Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance.

Authors:  Su Gao; Ryan P McMillan; Qingzhang Zhu; Gary D Lopaschuk; Matthew W Hulver; Andrew A Butler
Journal:  Mol Metab       Date:  2015-01-17       Impact factor: 7.422

Review 3.  Adropin- A Novel Biomarker of Heart Disease: A Systematic Review Article.

Authors:  Somaye Yosaee; Sepideh Soltani; Eghbal Sekhavati; Shima Jazayeri
Journal:  Iran J Public Health       Date:  2016-12       Impact factor: 1.429

4.  Serum adropin as a predictive biomarker of erectile dysfunction in coronary artery disease patients.

Authors:  Hüsetin Tugrul Celik; Mehmet Bilen; Fatmanur Kazancı; Mehmet Erol Yildirim; İlkay Bekir İncebay; Hüsamettin Erdamar
Journal:  Cent European J Urol       Date:  2019-07-08

Review 5.  Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications.

Authors:  Xiuxiu Wang; Xiaoyue Shen; Yuting Yan; Hongmin Li
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

6.  Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases.

Authors:  Fahimeh Varzideh; Urna Kansakar; Stanislovas S Jankauskas; Jessica Gambardella; Gaetano Santulli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-05       Impact factor: 5.555

7.  Myricetin Increases Circulating Adropin Level after Activation of Glucagon-like Peptide 1 (GLP-1) Receptor in Type-1 Diabetic Rats.

Authors:  Ying-Xiao Li; Kai-Chun Cheng; I-Min Liu; Ho-Shan Niu
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-31

8.  Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury.

Authors:  Feng Gao; Jun Fang; Falin Chen; Chengdang Wang; Shu Chen; Sheng Zhang; Xiaoting Lv; Jinchi Zhang; Qingliang He; Shaohuang Weng; Qicai Liu; Xin-Hua Lin
Journal:  EBioMedicine       Date:  2016-06-02       Impact factor: 8.143

9.  Serum adropin levels are reduced in patients with inflammatory bowel diseases.

Authors:  Darko Brnić; Dinko Martinovic; Piero Marin Zivkovic; Daria Tokic; Ivana Tadin Hadjina; Doris Rusic; Marino Vilovic; Daniela Supe-Domic; Ante Tonkic; Josko Bozic
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.